AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 99 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $166,000 | -50.9% | 471 | 0.0% | 0.00% | – |
| Q1 2022 | $338,000 | -68.2% | 471 | 0.0% | 0.00% | – |
| Q4 2021 | $1,064,000 | -21.5% | 471 | 0.0% | 0.00% | – |
| Q3 2021 | $1,356,000 | -13.5% | 471 | 0.0% | 0.00% | – |
| Q2 2021 | $1,568,000 | -1.6% | 471 | 0.0% | 0.00% | – |
| Q1 2021 | $1,594,000 | +20.8% | 471 | 0.0% | 0.00% | – |
| Q4 2020 | $1,319,000 | +11.6% | 471 | 0.0% | 0.00% | – |
| Q3 2020 | $1,182,000 | -81.5% | 471 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $6,396,000 | +79.2% | 471 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $3,570,000 | +1.4% | 471 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $3,522,000 | +90.8% | 471 | 0.0% | 0.00% | – |
| Q3 2019 | $1,846,000 | -19.0% | 471 | 0.0% | 0.00% | – |
| Q2 2019 | $2,279,000 | -40.9% | 471 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $3,856,000 | +48.1% | 471 | 0.0% | 0.00% | – |
| Q4 2018 | $2,604,000 | – | 471 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |